Reata draws Buy rating at Goldman on potential for neuromuscular disease therapy
March 24 2022 - 10:29AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Reata Pharmaceuticals (NASDAQ:RETA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Reata Pharmaceuticals (NASDAQ:RETA)
Historical Stock Chart
From Apr 2023 to Apr 2024